# Clenbuterol on Motor Function in Individuals With Amyotrophic Lateral Sclerosis

> **NCT04245709** · PHASE2 · COMPLETED · sponsor: **Dwight Koeberl, M.D., Ph.D.** · enrollment: 25 (actual)

## Conditions studied

- Amyotrophic Lateral Sclerosis

## Interventions

- **DRUG:** Clenbuterol

## Key facts

- **NCT ID:** NCT04245709
- **Lead sponsor:** Dwight Koeberl, M.D., Ph.D.
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-10
- **Primary completion:** 2021-03-10
- **Final completion:** 2021-03-10
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2022-09-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04245709

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04245709, "Clenbuterol on Motor Function in Individuals With Amyotrophic Lateral Sclerosis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04245709. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*